The Company continues to build the Quell ® Fibromyalgia business via direct-to-physician marketing and sales to Veterans Health Administration facilities. Quell revenue increased by 50% to $184,000 in ...
Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic ...